Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moseley

Showing results (351-360 of 376) with videos related to

Pageof 38
Sort By:
Journal of Medicinal Chemistry|October 16, 1992
Growth hormone-releasing factor analogs with hydrophobic residues at position 19. Effects on growth hormone releasing activity in vitro and in vivo, stability in blood plasma in vitro, and secondary structureA R Friedman, A K Ichhpurani, W M Moseley, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
International Journal of Experimental Pathology|June 1, 1992
An assessment of the ability of human bone marrow cultures to generate osteoclastsA M Flanagan, M A Horton, E L Dorey, et al.
Journal of General Internal Medicine|February 5, 2020
Exercise to Reduce Mobility Disability and Prevent Falls After Fall-Related Leg or Pelvic Fracture: RESTORE Randomized Controlled TrialCatherine Sherrington, Nicola Fairhall, Catherine Kirkham, et al.
Molecular Cancer Research : MCR|January 27, 2005
Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrixBedrich L Eckhardt, Belinda S Parker, Ryan K van Laar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Biotechnology and Applied Biochemistry|August 1, 1997
Use of the HIV-1 protease for excision of growth-hormone-releasing factor from synthetic and recombinant peptide precursorsA G Tomasselli, A A Mildner, D J Paddock, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohortsTarek M A Abdel-Fatah, Arvind Arora, Nouf Alsubhi, et al.
Frontiers in Immunology|September 27, 2018
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast CancerGemma A Foulds, Jayakumar Vadakekolathu, Tarek M A Abdel-Fatah, et al.
Brazilian Journal of Physical Therapy|November 20, 2024
The methodological quality of clinical trials of physical therapy for low back pain varies between countries with different income levels. A meta-epidemiological studyCarlos Maximiliano Sánchez Medina, Claudia Gutiérrez Camacho, Anne M Moseley, et al.
Pageof 38

Showing results (351-360 of 376) with videos related to

Sort By:
Pageof 38
Journal of Medicinal Chemistry|October 16, 1992
Growth hormone-releasing factor analogs with hydrophobic residues at position 19. Effects on growth hormone releasing activity in vitro and in vivo, stability in blood plasma in vitro, and secondary structureA R Friedman, A K Ichhpurani, W M Moseley, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
International Journal of Experimental Pathology|June 1, 1992
An assessment of the ability of human bone marrow cultures to generate osteoclastsA M Flanagan, M A Horton, E L Dorey, et al.
Journal of General Internal Medicine|February 5, 2020
Exercise to Reduce Mobility Disability and Prevent Falls After Fall-Related Leg or Pelvic Fracture: RESTORE Randomized Controlled TrialCatherine Sherrington, Nicola Fairhall, Catherine Kirkham, et al.
Molecular Cancer Research : MCR|January 27, 2005
Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrixBedrich L Eckhardt, Belinda S Parker, Ryan K van Laar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Biotechnology and Applied Biochemistry|August 1, 1997
Use of the HIV-1 protease for excision of growth-hormone-releasing factor from synthetic and recombinant peptide precursorsA G Tomasselli, A A Mildner, D J Paddock, et al.
Neoplasia (New York, N.Y.)|November 27, 2014
Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohortsTarek M A Abdel-Fatah, Arvind Arora, Nouf Alsubhi, et al.
Frontiers in Immunology|September 27, 2018
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast CancerGemma A Foulds, Jayakumar Vadakekolathu, Tarek M A Abdel-Fatah, et al.
Brazilian Journal of Physical Therapy|November 20, 2024
The methodological quality of clinical trials of physical therapy for low back pain varies between countries with different income levels. A meta-epidemiological studyCarlos Maximiliano Sánchez Medina, Claudia Gutiérrez Camacho, Anne M Moseley, et al.
Pageof 38